Innovation and Equity in an Age of Gene Editing
By Charis Thompson, Ruha Benjamin, Jessica Cussins and Marcy Darnovsky,
The Guardian
| 05. 19. 2015
The first day of BEINGS2015, “A Gathering of Global Thought Leaders to Reach Consensus on the Direction of Biotechnology for the 21st Century”, in Atlanta, coincided with the announcement by the National Academy of Science and National Academy of Medicine of an initiative to look into “promising new treatments for disease,” given that “recent experiments to attempt to edit human genes also have raised important questions about the potential risks and ethical concerns of altering the human germline.”
It is the time of prizes and tussles over intellectual property and experiments on non-viable human embryos, and, calls for caution from CRISPR-CAS9 scientists (here and here and here). Also still in the air is the UK’s political vote, despite an EU consensus against germline genetic modification (was this the first step of ‘Brexit’?) to allow clinics to apply for permission to undertake IVF with mitochondrial DNA donation, a form of germ cell genetic modification that requires egg donation. These technologies are widely considered threshold technologies with unknown and irreversible consequences for individuals, humanity and the environment.
During...
Related Articles
By Shivam Jadaun and Shivani, JURISTnews | 06.27.2024
Image by European Council from Flickr
In some European Union nations, the forced sterilisation of people with disabilities is still a widespread and concerning practice that blatantly violates their fundamental rights and human dignity. The scope of forced sterilisation in...
By Miri (Margaret) Raven, Alana Gall, Bibi Barba, and Daniel Robinson, The Conversation | 06.02.2024
Image by Ahmet Kurt from Unsplash
Last week, at a conference in Geneva, the member states of the World Intellectual Property Organisation agreed on a new treaty aimed at preventing the for-profit piracy of traditional knowledge.
So-called “biopiracy”, in...
By Osagie K. Obasogie, L.A. Review of Books | 04.17.2024
When Robert G. Edwards won the Nobel Prize in Physiology or Medicine in 2010 for developing in vitro fertilization (IVF) decades earlier in 1978, many members of the scientific community sighed in relief. This honor, they felt, was long...
By Ryan Cross, Endpoints News | 05.08.2024
A half-decade after a scientist’s reckless experiment with human embryos put a stop to much of China’s clinical work on CRISPR gene editing, local researchers are once again performing human studies of the technology.
At least three Chinese biotech companies...